Evidence map›Paper›PMID 8753857›Full record

ArticleImmunogenetics1996

Repression of the nonclassical MHC class I gene H2-M1 by cis-acting silencer DNA elements.

T K Howcroft, J D Weissman, S Rudikoff, W I Frels, D S Singer

Abstract read
PubMed Publisher
In one paragraph

Article in Immunogenetics, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

T K HowcroftExperimental Immunology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive MSC 1360, Bethesda, MD 20892-1360, USA.
J D Weissman
S Rudikoff
W I Frels
D S Singer
National Cancer Institute · USNational Institutes of Health · USBioqual · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

H2-M1 is a non-classical major histocompatibility complex (MHC) class I gene that is highly divergent from classical class I genes; M1 was the first gene in the recently classified M region of the mouse MHC to be cloned. Although the M1 DNA sequence contains normal splice sites, open reading frames within its exons, and a recognizable promoter, no M1 transcripts were detected in various healthy mouse tissues. However, M1 transcripts were detected in transfected L cells and in vivo in brains of M1 transgenic mice, albeit at very low levels, and the level of expression is correlated with transgene copy number. Analysis of the M1 promoter region identified a competent promoter capable of directing transcription, but whose expression is repressed by two strong upstream silencer elements, one mapping between -184 base pairs (bp) and -266 bp and the other between -1149 bp and -1702 bp. These studies suggest that M1 expression is highly regulated and restricted either temporally or to a very limited number of cell types.

Indexed as

Regulatory Sequences, Nucleic AcidAnimalsBase SequenceBlotting, NorthernBrain ChemistryExonsGenes, MHC Class IL CellsMiceMice, TransgenicMolecular Sequence DataOpen Reading FramesPolymerase Chain ReactionPromoter Regions, GeneticRNATranscription, GeneticRNA

Identifiers

PMID8753857
OpenAlexW2984247501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.